NCT02350634View on ClinicalTrials.gov

18F-AV-1451 High Resolution Autopsy Study

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

November 26, 2016

Primary Completion Date

June 16, 2017

Study Completion Date

June 16, 2017

Conditions
Alzheimer's Disease
Interventions
DRUG

Flortaucipir F18

Subjects will receive a single IV bolus injection of 370 megabecquerel (MBq) (10 millicurie \[mCi\]) of flortaucipir.

Trial Locations (2)

85006

Banner Alzheimer's Institute, Phoenix

94121

University of California, San Francisco, San Francisco

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY